Financial partners
VECT-HORUS continues its funding strategy with historic shareholders and also new entrants to grant the Company significant financial resources to carry out its research and development programs and leverage with public research grants.
 |
 |
 |
 |
 |
Vect-Horus received the agreement of Région Sud - Provence-Alpes-Côte d’Azur for a non-dilutive grant of more than 1 M€ from the REACT-EU program. This project is financed with the assistance of the European Union with the European Regional Development Fund in response to the COVID-19 pandemic.
Vect-Horus plans to optimize its R&D and production equipment to accelerate the demonstration of its technology VECTrans® and to ensure its development on a larger scale to meet the needs of its Pharma/Biotech partners and new challenges in therapy, in particular, in the development of innovative therapeutic approaches based on nucleic acids (siRNAs, ASOs, mRNAs) which require targeting and cellular transport technologies.
Academic partners
Close collaborations with top academic research centers: AMU, CEA, CERIMED, CNRS, INP, INSERM
 |
 |
 |
 |
 |
 |